New gel could ease painful skin growths
NCT ID NCT07552077
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests a gel called PTX-022 (sirolimus) on people aged 6 and older with angiokeratomas, which are small, raised skin spots. The study will check if the gel is safe and helps improve the appearance of these spots. Fifteen participants will apply the gel and be monitored for side effects and changes in their skin.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sirolimus topical gel (PTX-022)
What this could lead to
If successful, this gel could offer a non-invasive treatment option for angiokeratomas, potentially reducing the need for more aggressive procedures.
What could go wrong
This is a small, early-phase trial with only 15 participants, so results may not apply widely. The gel may cause skin irritation or not improve the condition significantly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGIOKERATOMAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleaver Medical Group
RECRUITINGDawsonville, Georgia, 30534, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Epiphany Dermatology
RECRUITINGSouthlake, Texas, 76092, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Unified Health
NOT_YET_RECRUITINGSherman Oaks, California, 91403, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Vividia Dermatology
NOT_YET_RECRUITINGLas Vegas, Nevada, 89148, United States
Contact Email: •••••@•••••
Contact